Sanofi Stock Price Patterns
| SNYNF Stock | USD 91.11 0.52 0.57% |
Momentum 40
Sell Extended
Oversold | Overbought |
Using Sanofi hype-based prediction, you can estimate the value of Sanofi from the perspective of Sanofi response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sanofi to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Sanofi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sanofi after-hype prediction price | USD 91.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sanofi |
Sanofi After-Hype Price Density Analysis
As far as predicting the price of Sanofi at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sanofi or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Sanofi, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sanofi Estimiated After-Hype Price Volatility
In the context of predicting Sanofi's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sanofi's historical news coverage. Sanofi's after-hype downside and upside margins for the prediction period are 89.45 and 92.77, respectively. We have considered Sanofi's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sanofi is very steady at this time. Analysis and calculation of next after-hype price of Sanofi is based on 3 months time horizon.
Sanofi Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sanofi is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanofi backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sanofi, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.67 | 0.00 | 0.09 | 0 Events / Month | 7 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
91.11 | 91.11 | 0.00 |
|
Sanofi Hype Timeline
Sanofi is at this time traded for 91.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.09. Sanofi is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.15%. %. The volatility of related hype on Sanofi is about 276.91%, with the expected price after the next announcement by competition of 91.20. About 47.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi has Price/Earnings To Growth (PEG) ratio of 1.63. The entity recorded earning per share (EPS) of 5.77. The firm last dividend was issued on the 6th of May 2022. Sanofi had 1005:1000 split on the 6th of May 2022. Assuming the 90 days horizon the next estimated press release will be within a week. Check out Sanofi Basic Forecasting Models to cross-verify your projections.Sanofi Related Hype Analysis
Having access to credible news sources related to Sanofi's direct competition is more important than ever and may enhance your ability to predict Sanofi's future price movements. Getting to know how Sanofi's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sanofi may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NVS | Novartis AG ADR | 0.27 | 8 per month | 1.13 | 0.11 | 2.59 | (2.32) | 6.07 | |
| AZN | AstraZeneca PLC ADR | 1.24 | 8 per month | 1.31 | 0.07 | 2.62 | (2.37) | 8.81 | |
| GSK | GlaxoSmithKline PLC ADR | (0.41) | 10 per month | 1.31 | 0.07 | 2.38 | (2.17) | 8.39 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.92 | 0.21 | 3.60 | (1.93) | 13.68 | |
| BMY | Bristol Myers Squibb | 3.55 | 35 per month | 1.04 | 0.16 | 3.59 | (1.98) | 11.16 | |
| SNY | Sanofi ADR | 0.22 | 9 per month | 0.00 | (0.18) | 1.87 | (2.19) | 5.92 | |
| BAYRY | Bayer AG PK | 0.00 | 0 per month | 1.31 | 0.25 | 6.41 | (2.90) | 15.49 | |
| MRK | Merck Company | (0.91) | 7 per month | 1.14 | 0.17 | 3.59 | (1.98) | 8.09 | |
| ABBV | AbbVie Inc | 3.68 | 8 per month | 0.00 | (0.05) | 2.95 | (2.86) | 8.22 | |
| GILD | Gilead Sciences | 2.01 | 9 per month | 1.34 | 0.11 | 3.01 | (2.41) | 6.70 | |
| JNJ | Johnson Johnson | (0.28) | 6 per month | 0.59 | 0.19 | 2.29 | (1.39) | 5.56 | |
| AMGN | Amgen Inc | 2.92 | 8 per month | 1.17 | 0.12 | 3.47 | (2.59) | 11.18 | |
| BIIB | Biogen Inc | (4.45) | 10 per month | 1.67 | 0.11 | 3.11 | (2.55) | 9.61 |
Sanofi Additional Predictive Modules
Most predictive techniques to examine Sanofi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sanofi using various technical indicators. When you analyze Sanofi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sanofi Predictive Indicators
The successful prediction of Sanofi stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sanofi, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sanofi based on analysis of Sanofi hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sanofi's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sanofi's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Sanofi Pink Sheet analysis
When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |